TP53 and urinary bladder carcinoma: p53 and PTEN regulate TAGLN to inhibit bladder cancer cell proliferation.[12] As a result, we now broaden the molecular interactome with TAGLN to add HDAC2 regulating p53 deacetylation at K382, in turn, mediating acceleration of cell cycle progression.